Dr Catrin Moore

Dr Catrin Moore’s research focuses on Antimicrobial resistance, often termed the silent pandemic, which is on the increase in many LMICs. Dr Moore has been in the University of Oxford for over twenty years in the Global arena, and her DPhiL was based in Oxford and Thailand. She moved to South East Asia following her DPhiL to build the local capacity in-country and ran diagnostic and research clinical microbiology laboratories for six years (based in Laos and Cambodia). Dr Moore returned to the UK in 2012 to join the Modernising Medical Microbiology laboratory, where she led a stream of work performing whole genome sequencing on Streptococcus pneumoniae. She moved to the Epidemic diseases Research Group Oxford in 2015, where she managed an Ebola clinical trial and led several genomic studies on avian influenza.

Dr Moore joined the Big Data Institute in May 2018, where she leads the Oxford Global Burden of Disease (GBD) group on the Global Research on AntiMicrobial resistance (GRAM) project. Partnered with the Institute for Health Metrics and Evaluation (IHME) in Seattle and Tropical Medicine in Oxford, they analyse global data to produce health metrics and geospatial maps on antimicrobial resistance (AMR). Utilizing methodologies applied in IHME’s ongoing Global Burden of Disease (GBD) study, the partnership builds global evidence on AMR with an initial focus on a select number of disease-resistant infections. Dr Moore also works on studies to improve the use of diagnostic tools, training, and communication in low- and middle-income countries (LMICs) to treat patients presenting to outpatient facilities to reduce the unnecessary prescribing of antibiotics.